Northwest Biotherapeutics, Inc. Share Price
Stocks
NWBO
US66737P6007
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1810 USD | -2.16% |
|
-4.84% | -20.89% |
| 05-15 | Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-21 | Northwest Biotherapeutics Establishes Dedicated Leukapheresis Clinic | CI |
| Market Cap | 307M 269M 248M 231M 436M 29.01B 444M 2.97B 1.15B 14.32B 1.15B 1.13B 49.87B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 403M 353M 326M 304M 572M 38.09B 582M 3.9B 1.52B 18.8B 1.51B 1.48B 65.49B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 11.1x |
| Free-Float |
95.04% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.16% | ||
| 1 week | -4.84% | ||
| Current month | -20.09% | ||
| 1 month | -17.95% | ||
| 3 months | -8.35% | ||
| 6 months | -20.44% | ||
| Current year | -20.89% |
| 1 week | 0.18 |  | 0.24 |
| 1 month | 0.18 | | 0.24 |
| Current year | 0.18 | | 0.34 |
| 1 year | 0.18 | | 0.37 |
| 3 years | 0.17 | | 1.09 |
| 5 years | 0.17 | | 2.05 |
| 10 years | 0.14 | | 2.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alton Boynton
CEO | Chief Executive Officer | 82 | 31/05/2007 |
Linda Powers
CEO | Chief Executive Officer | 71 | 07/06/2011 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 67 | 31/12/1999 |
| Director | Title | Age | Since |
|---|---|---|---|
Alton Boynton
BRD | Director/Board Member | 82 | 31/12/1997 |
Linda Powers
CHM | Chairman | 71 | 16/05/2007 |
Navid Malik
BRD | Director/Board Member | 57 | 31/03/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 28/08/24 | Don | Founder | 1,000,000 | 0.0826% | ||
| 08/08/24 | Don | Chief Technology Officer | 3,000,000 | 0.2478% | ||
| 07/08/24 | Don | Founder | 1,000,000 | 0.0826% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.16% | -4.84% | -24.55% | -68.13% | 307M | |
| +3.31% | -0.20% | +72.71% | +128.31% | 55.78B | |
| -1.32% | +16.55% | +89.14% | +101.41% | 55.66B | |
| -0.82% | +3.09% | -12.26% | -13.44% | 23.84B | |
| +3.34% | +5.05% | +6.63% | +408.58% | 22.7B | |
| +4.45% | +5.06% | +36.50% | -30.43% | 16.12B | |
| +0.51% | +6.41% | +23.95% | +185.87% | 13.64B | |
| +5.51% | +22.37% | +171.85% | +333.54% | 14.8B | |
| +2.80% | +5.08% | +78.27% | +133.56% | 12.16B | |
| -2.10% | +6.95% | +158.99% | +162.32% | 11.85B | |
| Average | +1.37% | +5.18% | +60.12% | +134.16% | 22.69B | |
| Weighted average by Cap. | +1.49% | +5.01% | +66.83% | +142.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 38.93M 34.08M 31.46M 29.34M 55.29M 3.68B 56.28M 377M 146M 1.82B 146M 143M 6.33B |
| Net income | - | - |
| Net Debt | 96.08M 84.1M 77.63M 72.41M 136M 9.08B 139M 931M 362M 4.48B 361M 353M 15.62B | 125M 109M 101M 94.17M 177M 11.81B 181M 1.21B 470M 5.83B 469M 459M 20.31B |
Employees
105
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/06/26 | US$0.1810 | -2.16% | 1,109,127 |
| 29/06/26 | US$0.1850 | -4.59% | 7,103,920 |
| 26/06/26 | US$0.1939 | +4.27% | 5,291,119 |
| 25/06/26 | US$0.1860 | -1.66% | 3,237,943 |
| 24/06/26 | US$0.1891 | -0.58% | 1,796,624 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1850USD
Average target price
1.000USD
Spread / Average Target
+440.54%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- NWBO Stock
Select your edition
All financial news and data tailored to specific country editions
